Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report)’s share price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.40 and traded as low as $2.18. Creative Medical Technology shares last traded at $2.27, with a volume of 8,355 shares.
Creative Medical Technology Price Performance
The company has a market cap of $3.97 million, a P/E ratio of -0.60 and a beta of 1.78. The stock has a fifty day moving average price of $2.40 and a two-hundred day moving average price of $3.12.
Creative Medical Technology Company Profile
Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.
Featured Articles
- Five stocks we like better than Creative Medical Technology
- EV Stocks and How to Profit from Them
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
